PCRX · Pacira BioSciences, Inc. · Documents
$36.38
-0.02 (-0.05%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.45B
Shares
39.86M
Volume · Oct 28
378.84K
Avg daily vol (3M)
1.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| SC TO-C | Pacira BioSciences, Inc. agreed to be acquired by Viatris through a cash tender offer of $36.50 per share, followed by a merger making Pacira a wholly owned Viatris subsidiary. The offer will remain open for 10 business days. | 2026-10-08 | — | |
| SC TO-C | Viatris Inc. agreed to acquire Pacira BioSciences, Inc. through a tender offer under an October 8, 2026 merger agreement; the planned acquisition would add two established medicines and expand Viatris’s non-opioid pain capabilities. The tender offer has not commenced. | 2026-10-08 | — | |
| 8-K | Pacira BioSciences, Inc. agreed to be acquired by Viatris Inc. through a cash tender offer for $36.50 per share, after which it would become a wholly owned Viatris subsidiary. The merger agreement is dated October 8, 2026. | 2026-10-08 | — | |
| 8-K | — | 2026-08-04 | — | |
| 10-Q | — | 2026-08-04 | 2026-06-30 | |
| 8-K | — | 2026-06-30 | 2026-06-28 | |
| 8-K | — | 2026-06-11 | 2026-06-09 | |
| Investor Event Transcript | — | 2026-06-08 | 2026-06-30 | |
| DEFA14A | — | 2026-06-04 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| DEFA14A | — | 2026-06-01 | — | |
| DEFA14A | — | 2026-05-28 | — | |
| DEFA14A | — | 2026-05-27 | — | |
| DEFA14A | — | 2026-05-26 | — | |
| DEFA14A | — | 2026-05-20 | — | |
| DEFA14A | — | 2026-05-20 | — | |
| DEFA14A | — | 2026-05-13 | — | |
| DEFA14A | — | 2026-05-12 | — | |
| DEFA14A | — | 2026-05-05 | — | |
| 8-K | — | 2026-04-30 | — | |
| 10-Q | — | 2026-04-30 | 2026-03-31 | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| Investor Event Transcript | — | 2026-03-11 | 2026-03-31 | |
| DEFA14A | — | 2026-03-11 | — | |
| 8-K | — | 2026-02-26 | — | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2026-01-28 | 2026-01-27 | |
| 8-K | — | 2026-01-08 | — | |
| 8-K | — | 2025-11-06 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-08-05 | — | |
| 10-Q | — | 2025-08-05 | 2025-06-30 | |
| 8-K | — | 2025-07-10 | 2025-07-09 | |
| 8-K | — | 2025-07-07 | 2025-07-03 | |
| 8-K | — | 2025-06-13 | 2025-06-10 | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| 8-K | — | 2025-05-08 | — | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEFA14A | — | 2025-04-29 | — | |
| DEF 14A | — | 2025-04-29 | 2024-06-10 | |
| 8-K | — | 2025-04-22 | 2025-04-17 | |
| DEFA14A | — | 2025-04-18 | — | |
| DEFA14A | — | 2025-04-17 | — | |
| 8-K | — | 2025-04-07 | — | |
| DEFA14A | — | 2025-03-14 | — | |
| 8-K | — | 2025-03-14 | 2025-03-12 | |
| 8-K | — | 2025-02-27 | — | |
| 10-K | — | 2025-02-27 | 2024-12-31 | |
| 8-K | — | 2025-01-30 | 2025-01-28 |
Showing 1–50 of 169 filings
Key facts
CIK
1396814
CUSIP
695127100
13F (30d)
51 filings
50 filers
Visit website
Investor relations